Eurofins BioPharma Services Newsletter 28 - February 2021
ARTICLES:
- Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
- Eurofins holds a wealth of cGMP experience testing RNA based drugs
- Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
- Targeting pro-inflammatory cytokines for COVID-19 therapy: Qualified cell-based assays for accelerated drug discovery
- Eurofins launches new tests and massive capacity to detect and monitor new variants of SARS-CoV-2
- Testing disinfectants for virucidal efficacy, a daily job at Eurofins!
Download the PDF version of pharma newsletter N°28
